The modern hospital operates like a tightly woven network of lifeโ€‘saving equipment, where every infusion pump, imaging scanner, and patient monitor is both a critical caregiver and a potential entry point for cyber threats. Unlike traditional IT assets, these devices cannot be simply powered down for a patch without jeopardizing ongoing care, which forces security teams to schedule updates around surgical shifts, emergency admissions, and equipment redundancies. The result is a tension between patient safety and cyber hygiene that has long been managed through adโ€‘hoc spreadsheets, endless email chains, and manual ticketing systems that rarely produce an auditable trail. This fragmented approach leaves known weaknesses lingering far longer than they should, exposing hospitals to ransomware, data theft, and potentially lifeโ€‘threatening device manipulation. Recognizing this gap, Gluware has taken the automation expertise it honed over nearly two decades in enterprise networking and redirected it toward the unique constraints of clinical environments. The goal is to give biomedical engineers, security analysts, and compliance officers a single, trusted workflow that takes a vulnerability disclosure from public notice to a fully documented, approved patchโ€”without pulling a single device offline outside of its maintenance window.

Gluware IoMT Exposure Management builds directly on the companyโ€™s proven automation platform, which already orchestrates configuration changes across routers, switches, firewalls, and dataโ€‘center hardware from dozens of vendors. At its core lies the DIALโ„ข (Device Interaction and Automation Layer), a semantic translation engine that understands the command sets, data models, and state information of more than fifty operating systems and two dozen hardware families. By abstracting the lowโ€‘level details of each device, DIAL lets the same policyโ€‘driven automation logic be applied to a bedside monitor as easily as to a core switch. Rather than forcing hospitals to purchase yet another point solution that would require its own connectors, training, and support contracts, Gluware simply extends the existing engine to recognize medicalโ€‘device identifiers, map them to vulnerability feeds, and launch remediation actions within the institutionโ€™s approved changeโ€‘control framework. This approach means that the same team that already schedules nightly router upgrades can now also schedule a firmware update for an infusion pump, using the same approval workflow, the same audit log, and the same reporting dashboard. The net effect is a reduction in tool sprawl, a lower total cost of ownership, and a faster path from vulnerability disclosure to mitigated risk.

For years, hospitals have invested in vulnerability scanners and asset inventories that do a respectable job of flagging which CVEs could affect their equipment. The difficulty begins after that alert appears: security staff must crossโ€‘reference the scanner output with a clinical asset database, determine which specific models are affected, locate the appropriate patch from the manufacturer, and then open a change request that satisfies both IT governance and clinical operations. In many institutions, each of those steps lives in a different systemโ€”one team runs the scanner in a security console, another maintains the CMMS in a maintenance department, and a third handles change tickets in a serviceโ€‘now style tool. Handing information off between these silos introduces delays, transcription errors, and gaps where the audit trail disappears. A patch might be approved in the ticketing system but never linked back to the device record, leaving auditors unable to verify that the fix was actually applied. Moreover, because clinical devices often run on outdated or proprietary operating systems, the patch itself may require a special reboot sequence or a temporary shift to a backup unit, adding layers of coordination that manual processes struggle to track. The cumulative effect is a remediation cycle that can stretch from weeks to months, during which known exploits remain active and the hospitalโ€™s risk profile stays elevated.

The volume of new vulnerability disclosures has been climbing at an unprecedented pace. Data from the National Institute of Standards and Technology shows that the number of CVE entries published each year rose by more than 260 percent between 2020 and 2025, a trend that shows no sign of slowing as software complexity grows and more devices become networkโ€‘enabled. Hospitals, however, have not seen a matching expansion in the staff or automation needed to turn each disclosure into a concrete remediation task. Consequently, the average connected medical device now carries over six known weaknesses, and a substantial portion of infusion pumpsโ€”roughly three out of fourโ€”harbor at least one flaw that appears in CISAโ€™s Known Exploited Vulnerabilities catalog. Adding to the challenge, about six in ten devices in the field are running components that have fallen out of vendor support, meaning no official patches exist and mitigations must rely on workarounds or network segmentation. This growing backlog is not merely a technical nuisance; it translates directly into a larger attack surface for ransomware gangs, nationโ€‘state actors, and insider threats who increasingly target healthcare for its highโ€‘value data and the potential to disrupt critical care.

The financial stakes of a breach in healthcare are among the highest of any industry. IBMโ€™s annual Cost of a Data Breach report has consistently placed healthcare at the top, with the average incident in 2025 exceeding $7.4 million when accounting for detection, escalation, notification, lost business, and postโ€‘event response. Those figures capture more than just the immediate costs of forensic analysis and regulatory fines; they reflect the longerโ€‘term impact on patient trust, potential litigation, and the expense of implementing emergency security measures after an attack. When a vulnerability in a medical device leads to unauthorized access to patient records or, worse, manipulation of therapy delivery, the consequential damages can rise far beyond the baseline number, encompassing regulatory penalties under HIPAA, loss of Medicare reimbursement eligibility, and damage to a providerโ€™s reputation that can take years to rebuild. In this context, investing in automated remediation is not merely an IT efficiency play; it is a riskโ€‘management strategy that directly protects revenue streams, preserves clinical continuity, and helps avoid the multimillionโ€‘dollar fallout that follows a serious security incident.

The technical backbone that makes Gluware IoMT Exposure Management possible is the DIALโ„ข layer, a technology the company has refined through thousands of deployments across diverse industries. DIAL operates by constructing a canonical model of each deviceโ€™s configuration and state, then mapping vendorโ€‘specific commands and responses onto that model. When a new vulnerability is announced, the platform ingests the CVE description, extracts the affected product names, versions, and component identifiers, and then queries the hospitalโ€™s asset inventory to find exact matches. Once a match is confirmed, the solution consults a curated patch repositoryโ€”fed by manufacturer advisories, vendor portals, and trusted thirdโ€‘party sourcesโ€”to determine the appropriate remediation action, whether that is a firmware upload, a configuration toggle, or a temporary network isolation step. Throughout this process, DIAL ensures that the exact sequence of commands sent to the device respects its operational constraints, such as requiring a standby mode or confirming a successful reboot before declaring the task complete. Because the same layer is used for networking gear, the hospitalโ€™s existing automation scripts, policy definitions, and approval workflows can be reused without modification, dramatically lowering the barrier to adoption.

Traditional remediation workflows are broken up into five distinct stages: vulnerability ingestion, deviceโ€‘toโ€‘CVE matching, patch selection, changeโ€‘request creation, and postโ€‘implementation verification. In many hospitals each stage is owned by a different group and facilitated by a separate tool, leading to a series of handoffs where information must be exported, reformatted, and reโ€‘entered manually. These handoffs are fertile ground for delay: a security analyst might finish the matching step at 5โ€ฏp.m., but the change request does not get opened until the next morning because the ticketing system is managed by a different shift. Moreover, the manual nature of the transfer often severs the link between the original vulnerability record and the final change ticket, forcing auditors to reconstruct the story from logs, emails, and spreadsheetsโ€”a process that is both timeโ€‘consuming and errorโ€‘prone. Gluwareโ€™s IoMT Exposure Management collapses those five stages into a single, continuous pipeline. As soon as a CVE is published, the platform automatically performs the match, identifies the patch, builds a change request that includes the device serial number, the exact CLI or API commands to run, and attaches the approval workflow predefined by the hospital. Once the change is executed, the system logs the outcome, ties it back to the original CVE, and makes the full record available for reporting and audit with a single click. By eliminating the intermediate steps, hospitals can shrink remediation cycles from weeks to days while preserving a transparent, immutable trail.

The inspiration for this solution came directly from a realโ€‘world pain point at The Ohio State University Wexner Medical Center. The academic hospital had already deployed Gluware to automate its core network infrastructure and had achieved a clear, realโ€‘time view of its connected medicalโ€‘device fleet through an assetโ€‘discovery integration. Yet when it came to actually fixing the vulnerabilities that scanners flagged, the biomedical engineering team found itself jumping between a security console, a maintenance management system, and a serviceโ€‘nowโ€‘style ticketing platform, copying and pasting data by hand. Those workflow fractures meant that known weaknesses remained open longer than clinicians felt comfortable with, especially on highโ€‘usage devices like infusion pumps that support critical therapies around the clock. Recognizing that the same automation engine that kept its routers compliant could also shepherd a medical device through the entire patch lifecycle, the hospitalโ€™s Deputy CIO and CTO, Siji Atekoja, partnered with Gluwareโ€™s engineers to prototype a seamless flow. They began by feeding the centerโ€™s device inventory into the DIAL layer, then added a vulnerabilityโ€‘matching module that pulled CVE data from NIST and manufacturer feeds, and finally wired the output into the existing changeโ€‘control process used for network upgrades. The resulting prototype proved that the hospital could cut its average remediation time by more than half while generating a complete, auditable record for each fix. That collaborative effort became the foundation of Gluware IoMT Exposure Management, demonstrating that the best innovations often arise when vendors listen closely to the operational realities of their customers.

Regulatory expectations in healthcare are exceptionally stringent when it comes to change management. Agencies such as the FDA, CMS, and various state health departments require that any alteration to a medical deviceโ€™s software or configuration be documented, reviewed, and traceable to an authorized individualโ€”not merely for cybersecurity reasons, but to ensure that patient safety is not compromised. Traditional manual processes often fall short because the approval captured in a ticketing system may not reference the exact device serial number, the precise firmware version installed, or the time the device was returned to service. Gluwareโ€™s approach addresses this by embedding the approval and audit trail directly into the automation execution. When a change request is generated, it includes fields for the device identifier, the CVE being addressed, the patch source, the commanded actions, and the designated approver(s). The platform then enforces that the change cannot proceed until the required signaturesโ€”whether electronic approvals in a workflow tool or documented signโ€‘offs in a changeโ€‘management boardโ€”are recorded. After the patch is applied, the system automatically captures the preโ€‘ and postโ€‘change state, verifies that the device reports the expected version, and stores a cryptographic hash of the firmware image as proof of integrity. This endโ€‘toโ€‘end traceability not only satisfies auditors but also gives clinical leaders confidence that every modification has been vetted for both security and safety.

From a market perspective, Gluwareโ€™s move highlights a broader trend toward consolidation of automation capabilities across disparate device domains. Historically, organizations have bought point solutions for network configuration management, server patching, cloud workload hardening, and now, increasingly, for medicalโ€‘device vulnerability remediation. Each of these tools brings its own licensing model, skill set, and integration overhead, leading to a fragmented stack that is costly to maintain and difficult to scale. By demonstrating that a single semantic translation layer can serve networking gear, servers, and medical equipment alike, Gluware is positioning itself as a platform play that can reduce vendor sprawl while delivering deeper crossโ€‘domain visibility. Analysts predict that the market for integrated infrastructure automation will expand at a compound annual growth rate of roughly 15 percent over the next five years, driven by the need to secure heterogeneous environments under unified governance. Hospitals that adopt such a platform early stand to gain not only immediate reductions in risk but also a strategic advantage as they look to automate other clinical systemsโ€”such as laboratory analyzers, pharmacy robots, and buildingโ€‘management controlsโ€”under the same framework.

For healthcare leaders evaluating whether to pilot Gluware IoMT Exposure Management, a few practical steps can help ensure a smooth start. First, conduct a thorough inventory audit to confirm that the asset management system in use can export device identifiers (such as MAC address, serial number, and model) in a format compatible with the DIAL layerโ€”most modern CMMS and networkโ€‘accessโ€‘control tools already support CSV or API feeds. Second, define a clear scope for the initial project: choose a device class with a high volume of known vulnerabilities but relatively low clinical disruption risk, such as bedside patient monitors or infusion pumps that have redundant units available. Third, involve the changeโ€‘control board early to map the existing approval workflow into the platformโ€™s policy engine; this ensures that the automation respects the hospitalโ€™s specific governance rules without requiring process redesign. Fourth, establish success metrics up frontโ€”mean time to remediate, percentage of vulnerabilities closed within SLA, auditโ€‘ready report generation time, and staff hours saved on manual ticketing. Finally, schedule a knowledgeโ€‘transfer session with Gluwareโ€™s implementation team to run a tabletop exercise that simulates a CVE disclosure from detection to patch verification, allowing stakeholders to see the endโ€‘toโ€‘end flow in action before going live.

In closing, the extension of Gluwareโ€™s automation prowess to the Internet of Medical Things offers a compelling answer to a persistent and costly problem: the gap between knowing a vulnerability exists and actually fixing it on the equipment that delivers patient care. By unifying discovery, matching, patch selection, change approval, and verification into a single, auditable pipeline, the solution reduces the window of exposure, curtails the manual labor that has long plagued biomedical teams, and aligns cybersecurity practices with the rigorous safety standards demanded in clinical settings. Hospitals that act now can not only lower their immediate risk of ransomware and dataโ€‘breach losses but also lay the groundwork for a future where every connected deviceโ€”from imaging suites to wearable telemetryโ€”is managed with the same confidence and efficiency as the core network. The recommendation is simple: start with a focused pilot, measure the impact against concrete baselines, and expand the automation footprint as proof of value accumulates. In an era where the cost of a single breach can exceed seven million dollars, investing in automated, compliant remediation is not just a technical upgrade; it is a strategic imperative for preserving both patient safety and fiscal health.